Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Pfizer has struck a $2 billion deal with YaoPharma to develop and commercialize a phase 1 small-molecule GLP-1 receptor agonist for chronic weight management [1]
Finding balance with PCOS takes more than medication
10.1186/1475-2840-12-1 41 UrvaS.QuinlanT.LandryJ.MartinJ.LoghinC
This communication is for information and education purposes only and should not be taken as investment advice, a personal recommendation, or an offer of, or solicitation to buy or sell, any financial instruments
US$ 26.57
US$ 21.56
US$ 22.35
